You are here

Xtampza ER

Marketing police send 2018's first enforcement letter to Collegium over misleading opioid exhibit booth

Fierce Pharma

Wed, 02/28/18 - 09:21 am

Collegium Pharmaceutical

FDA Goes Farther Down the 3-Year Exclusivity Rabbit Hole With XTAMPZA ER-ROXYBOND Exclusivity Decision

FDA Law Blog

Wed, 08/16/17 - 10:03 am

Hatch Waxman Act

Why Endo's Bad News Sent Collegium Pharmaceutical Shares Soaring 10%

Motley Fool

Sun, 06/11/17 - 05:04 pm

Endo International

Collegium Pharmaceutical

Is a Hatch-Waxman 30-Month Stay Terminated if the Dismissal of a Patent Infringement Action is Later Vacated? FDA Says “No”

FDA Law Blog

Wed, 03/29/17 - 09:03 am

Hatch Waxman Act

Collegium Pharmaceutical

Collegium's pain drug wins a 'tentative' FDA approval with Purdue blocking the way

Fierce Biotech

Mon, 11/9/15 - 03:45 pm

Collegium Pharmaceutical